These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 14967828)

  • 1. How does angiotensin II cause renal injury?
    Long DA; Price KL; Herrera-Acosta J; Johnson RJ
    Hypertension; 2004 Apr; 43(4):722-3. PubMed ID: 14967828
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiotensin converting enzyme inhibition and the kidney.
    Hollenberg NK
    Curr Opin Cardiol; 1988; 3(Suppl 1):S19-29. PubMed ID: 11538849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldosterone in progressive renal disease.
    Hostetter TH; Rosenberg ME; Ibrahim HN; Juknevicius I
    Semin Nephrol; 2001 Nov; 21(6):573-9. PubMed ID: 11709805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue angiotensin generation and regulation of vascular tone.
    Cockcroft JR; O'Kane KP; Webb DJ
    Pharmacol Ther; 1995 Feb; 65(2):193-213. PubMed ID: 7792315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theoretical basis and clinical evidence for differential effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor subtype 1 blockers.
    Weir MR; Henrich WL
    Curr Opin Nephrol Hypertens; 2000 Jul; 9(4):403-11. PubMed ID: 10926177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II and its receptors in the diabetic kidney.
    Burns KD
    Am J Kidney Dis; 2000 Sep; 36(3):449-67. PubMed ID: 10977776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The renin-angiotensin system and vascular function. The role of angiotensin II, angiotensin-converting enzyme, and alternative conversion of angiotensin I.
    Roks A; Buikema H; Pinto YM; van Gilst WH
    Heart Vessels; 1997; Suppl 12():119-24. PubMed ID: 9476561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Renin-angiotensin system: current view].
    del Río A
    Med Clin (Barc); 1991 Jun; 97(1):17-20. PubMed ID: 1649939
    [No Abstract]   [Full Text] [Related]  

  • 9. [Angiotensin-converting enzyme inhibitors: effects on renal physiology and applications in hypertension and renal disease].
    Cofán F; Romero R
    Rev Clin Esp; 1993 Jan; 192(1):31-8. PubMed ID: 8465029
    [No Abstract]   [Full Text] [Related]  

  • 10. The benefits of angiotensin II receptor blockers in patients with renal insufficiency or failure.
    Venkata C; Ram S; Fierro G
    Am J Ther; 1998 Mar; 5(2):101-5. PubMed ID: 10099045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of angiotensin II on the kidney: does an angiotensin II receptor blocker make sense?
    Hollenberg NK
    Am J Kidney Dis; 2000 Sep; 36(3 Suppl 1):S18-23. PubMed ID: 10986155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant hypertension - the role of the paracrine renin-angiotensin system.
    Fleming S
    J Pathol; 2000 Oct; 192(2):135-9. PubMed ID: 11004688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibition in renal and hypertensive disorders.
    Götz R; Heidbreder E; Heidland A
    Clin Physiol Biochem; 1990; 8 Suppl 1():25-32. PubMed ID: 2257721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease.
    Kobori H; Nangaku M; Navar LG; Nishiyama A
    Pharmacol Rev; 2007 Sep; 59(3):251-87. PubMed ID: 17878513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the renin-angiotensin system in essential hypertension.
    Paran E; Nemenoff RA; Schrier RW
    Curr Opin Nephrol Hypertens; 1995 Jul; 4(4):295-9. PubMed ID: 7552093
    [No Abstract]   [Full Text] [Related]  

  • 16. Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic rat.
    Whaley-Connell AT; Chowdhury NA; Hayden MR; Stump CS; Habibi J; Wiedmeyer CE; Gallagher PE; Tallant EA; Cooper SA; Link CD; Ferrario C; Sowers JR
    Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1308-14. PubMed ID: 16788142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium sensitive hypertension: renal and adrenal non-modulation in its pathogenesis.
    Hollenberg NK; Williams GH
    Kidney; 1988 Nov; 21(3):13-8. PubMed ID: 11538850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimizing the progression of kidney disease. Introduction.
    Flack JM
    Am J Kidney Dis; 2000 Sep; 36(3 Suppl 1):S1-3. PubMed ID: 11023435
    [No Abstract]   [Full Text] [Related]  

  • 19. [Angiotensin-converting enzyme inhibitors as first choice drugs in chronic congestive heart failure].
    Adamska-Dyniewska H
    Pol Arch Med Wewn; 1992; 88(2-3):165-70. PubMed ID: 1337204
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of ACE2 in pulmonary diseases--relevance for the nephrologist.
    Oudit GY; Imai Y; Kuba K; Scholey JW; Penninger JM
    Nephrol Dial Transplant; 2009 May; 24(5):1362-5. PubMed ID: 19228756
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.